AUDREY FENWICK: Open Payments
NPI 1922585108 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,202 in 45 payments from 13 companies in 2025. Trend: 2023 $15,414 · 2024 $5,672 · 2025 $6,202
Speaker / faculty: $3,345Travel & lodging: $1,509Food & beverage: $1,249Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 17 | $5,353 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $218 |
| Astellas Pharma Global Development | 1 | $150 |
| Radius Health, Inc. | 2 | $141 |
| Biogen, Inc. | 6 | $135 |
| ABBVIE INC. | 2 | $49 |
| MILLICENT US INC | 3 | $44 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
| Amgen Inc. | 1 | $19 |
| Hologic Sales and Service, LLC | 1 | $17 |
Products named: Veozah, Tymlos, ZURZUVAE, BIJUVA, MYFEMBREE, VRAYLAR, FEMLYV, EVENITY.
Industry payments across IL — which companies pay providers there.
